Subcutaneous ertapenem delivered by an Australian outpatient parenteral antimicrobial therapy service: a retrospective comparative efficacy study

Jonathan Hiew, Timothy Whitmore, Mahalia McEvoy, Deborah Weatherall, Paul R. Ingram, Laurens Manning

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

Subcutaneous (SC) administration of ertapenem in outpatient parenteral antimicrobial therapy (OPAT) services may be a practical alternative to intravenous delivery for complicated infections. The clinical features and outcomes according to route of administration were compared from a large Australian OPAT service. Chronic renal impairment was more common in the SC group, reflecting an opportunity for route of administration as a vein preservation strategy. Adverse events were uncommon and successful outcomes were not different between the groups.

Original languageEnglish
Pages (from-to)1717-1721
Number of pages5
JournalInternal Medicine Journal
Volume51
Issue number10
DOIs
Publication statusPublished - Oct 2021

Fingerprint

Dive into the research topics of 'Subcutaneous ertapenem delivered by an Australian outpatient parenteral antimicrobial therapy service: a retrospective comparative efficacy study'. Together they form a unique fingerprint.

Cite this